Immunocore at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Immunocore brings 1 presentation to SCOPE 2027 in Orlando. Its program centers on how a biotech grows from early clinical wins to running Phase 3 trials worldwide, in the SCOPE Biotech Forum. It covers the people, processes, technology and governance a company must put in place to scale.

OrganizationSCOPE 2027 Attendance
Immunocore
Abingdon, UK
immunocore.com
Biotech
Develops T cell receptor bispecific medicines and markets Kimmtrak for uveal melanoma.
Panel
Wed Mar 3
3:25pm–3:50pm
From Early-Stage Success to Global Phase 3 Execution: How Biotechs Can Build the People, Processes, Technology, and Governance to Scale
SCOPE Biotech Forum · with Amgen, Alpheus Medical, AskBio
Trial design and deliveryOutsourcing and budgeting

Explore the full SCOPE 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full SCOPE 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Immunocore

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction